3-10145330-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000551.4(VHL):​c.341-1184A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.892 in 152,240 control chromosomes in the GnomAD database, including 60,696 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.89 ( 60696 hom., cov: 33)

Consequence

VHL
NM_000551.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.259

Publications

4 publications found
Variant links:
Genes affected
VHL (HGNC:12687): (von Hippel-Lindau tumor suppressor) This gene encodes a component of a ubiquitination complex. The encoded protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. In addition to oxygen-related gene expression, this protein plays a role in many other cellular processes including cilia formation, cytokine signaling, regulation of senescence, and formation of the extracellular matrix. Variants of this gene are associated with von Hippel-Lindau syndrome, pheochromocytoma, erythrocytosis, renal cell carcinoma, and cerebellar hemangioblastoma. [provided by RefSeq, Jun 2022]
VHL Gene-Disease associations (from GenCC):
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • von Hippel-Lindau disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • renal cell carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • autosomal recessive secondary polycythemia not associated with VHL gene
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics
  • Chuvash polycythemia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.928 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VHLNM_000551.4 linkc.341-1184A>G intron_variant Intron 1 of 2 ENST00000256474.3 NP_000542.1
VHLNM_001354723.2 linkc.*17+2309A>G intron_variant Intron 2 of 2 NP_001341652.1
VHLNM_198156.3 linkc.340+3143A>G intron_variant Intron 1 of 1 NP_937799.1
VHLNR_176335.1 linkn.670-1184A>G intron_variant Intron 2 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VHLENST00000256474.3 linkc.341-1184A>G intron_variant Intron 1 of 2 1 NM_000551.4 ENSP00000256474.3

Frequencies

GnomAD3 genomes
AF:
0.892
AC:
135697
AN:
152122
Hom.:
60660
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.936
Gnomad AMI
AF:
0.881
Gnomad AMR
AF:
0.870
Gnomad ASJ
AF:
0.928
Gnomad EAS
AF:
0.885
Gnomad SAS
AF:
0.791
Gnomad FIN
AF:
0.902
Gnomad MID
AF:
0.842
Gnomad NFE
AF:
0.875
Gnomad OTH
AF:
0.883
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.892
AC:
135783
AN:
152240
Hom.:
60696
Cov.:
33
AF XY:
0.893
AC XY:
66447
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.936
AC:
38902
AN:
41558
American (AMR)
AF:
0.870
AC:
13286
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.928
AC:
3220
AN:
3470
East Asian (EAS)
AF:
0.885
AC:
4589
AN:
5186
South Asian (SAS)
AF:
0.790
AC:
3814
AN:
4826
European-Finnish (FIN)
AF:
0.902
AC:
9555
AN:
10592
Middle Eastern (MID)
AF:
0.844
AC:
248
AN:
294
European-Non Finnish (NFE)
AF:
0.875
AC:
59516
AN:
68024
Other (OTH)
AF:
0.876
AC:
1851
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
741
1482
2222
2963
3704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
900
1800
2700
3600
4500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.882
Hom.:
5206
Bravo
AF:
0.894
Asia WGS
AF:
0.824
AC:
2867
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
9.1
DANN
Benign
0.91
PhyloP100
0.26
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs779812; hg19: chr3-10187014; API